Baweja R, Soutullo CA, Waxmonsky JG. Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care. World J Psychiatr 2021; 11(12): 1206-1227 [PMID: 35070771 DOI: 10.5498/wjp.v11.i12.1206]
Corresponding Author of This Article
Raman Baweja, MD, MS, Associate Professor, Department of Psychiatry and Behavioral Health, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, United States. rbaweja@pennstatehealth.psu.edu
Research Domain of This Article
Psychiatry
Article-Type of This Article
Review
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Psychiatr. Dec 19, 2021; 11(12): 1206-1227 Published online Dec 19, 2021. doi: 10.5498/wjp.v11.i12.1206
Review of barriers and interventions to promote treatment engagement for pediatric attention deficit hyperactivity disorder care
Raman Baweja, Cesar A Soutullo, James G Waxmonsky
Raman Baweja, James G Waxmonsky, Department of Psychiatry and Behavioral Health, Penn State College of Medicine, Hershey, PA 17033, United States
Cesar A Soutullo, Louis A. Faillace, MD Department of Psychiatry and Behavioral Sciences, The University of Texas Health Science Center at Houston, Houston, TX 77054, United States
Author contributions: Baweja R conceptualized this paper, draft the initial manuscript, reviewed and revised the manuscript; Soutullo CA contributed in the initial manuscript, reviewed and revised the manuscript; Waxmonsky JG conceptualized this paper, contributed in the initial manuscript, critically reviewed and revised the manuscript; All authors approved the final manuscript as submitted and agree to accountable for all aspect of the work.
Conflict-of-interest statement: Soutullo CA reports non-personal research funds from Texas Child Mental Health Care Consortium (Youth Depression & Suicide Network) SB11, Lundbeck and Janssen; is a consultant and advisory board member of Editorial Médica Panamericana, EUNETHYDIS (European Network on Hyperkinetic Disorder), NeuroTech Solutions Ltd-Israel, Limbix -United States and Shire - Spain; received speaker’s bureau fees from Bial- Portugal, Medice -Germany, Rubio-Spain and Shire-Spain, and royalties from Editorial Médica Panamericana - Spain; Waxmonsky JG has received research funding from Supernus, and Pfizer, is a consultant for Purdue Pharma, Intracellular Therapies; Baweja R reports no conflicts of interest related to the subject of this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Raman Baweja, MD, MS, Associate Professor, Department of Psychiatry and Behavioral Health, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, United States. rbaweja@pennstatehealth.psu.edu
Received: March 26, 2021 Peer-review started: March 26, 2021 First decision: June 17, 2021 Revised: June 20, 2021 Accepted: October 25, 2021 Article in press: October 25, 2021 Published online: December 19, 2021 Processing time: 263 Days and 12.7 Hours
Core Tip
Core Tip: Assessment of families’ motivation for care at treatment initiation and recurrently over the course of treatment, especially during times of increasing stress and declining functioning, is essential to promote sustained engagement. Aspects of motivation that predict sustained engagement include desire and readiness for care, treatment preferences, self-efficacy to access and implement the selected treatment and perceived barriers to the treatment. Integrating services into trusted medical settings to reduce stigma, telehealth to reduce the burden of care, shared decision making to promote autonomy, psychoeducation about treatment options and how attention deficit hyperactivity disorder impacts current functioning and motivational interviewing can be employed to promote engagement.
